There is an urgent need for vaccines and therapeutics to prevent and treat COVID-19. Rapid
SARS-CoV-2 countermeasure development is contingent on the availability of robust …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected at least 180
million people since its identification as the cause of the current COVID-19 pandemic. The …

The global pandemic of coronavirus disease 2019 (COVID-19) is a disaster for human
society. A convenient and reliable neutralization assay is very important for the development …

Background SARS-CoV-2 is a novel coronavirus that emerged in 2019 and is now classified
in the genus Coronavirus with closely related SARS-CoV. SARS-CoV-2 is highly pathogenic …

SARS-CoV-2 enters cells using its Spike protein, which is also the main target of neutralizing
antibodies. Therefore, assays to measure how antibodies and sera affect Spike-mediated …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of
human infections, and an effective vaccine is critical to mitigate coronavirus-induced disease …

The emergence of SARS-CoV-2 and the ensuing explosive epidemic of COVID-19 disease
has generated a need for assays to rapidly and conveniently measure the antiviral activity of …

The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus requires reliable assays
for studying viral entry mechanisms which remains poorly understood. This knowledge is …

The severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) Spike glycoprotein is
solely responsible for binding to the host cell receptor and facilitating fusion between the …

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2, a new member of the
genus Betacoronavirus, is a pandemic virus, which has caused numerous fatalities …